$4.07
-0.44 (-9.76%)
Open$4.44
Previous Close$4.51
Day High$4.86
Day Low$4.00
52W High$13.69
52W Low$3.98
Volume—
Avg Volume24.7K
Market Cap25.42M
P/E Ratio—
EPS$-7.31
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+52.1% upside
Current
$4.07
$4.07
Target
$6.19
$6.19
$4.22
$6.19 avg
$8.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.12M | 2.07M | 10.09M |
| Net Income | -12,391,249 | -20,667,390 | -1,613,644 |
| Profit Margin | -1,106.7% | -1,051.4% | -16.0% |
| EBITDA | -44,587,235 | -78,498,653 | -2,029,249 |
| Free Cash Flow | — | — | -1,586,727 |
| Rev Growth | -46.0% | -46.0% | -9.4% |
| Debt/Equity | 0.00 | 0.00 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |